• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

5 of Today's Biggest Marijuana Stock Losers - Friday, March 16th

March 16, 2018

 

Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Friday, March 16th including Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) and more...

 

22nd Century Group, Inc. (NYSE:XXII)

 

Shares of 22nd Century Group, Inc. dropped 6.42% today on higher than average trading volume, closing the day at $2.48 USD per share. Earlier this week, another company began trials on a method for reducing gastric distress for edible forms of nicotine.

 

Cara Therapeutics, Inc. (NASDAQ:CARA)

 

Shares of Cara Therapeutics, Inc. dropped 5.56% on higher than average trading volume, closing the day at $12.56 USD per share. Yesterday, Cara announced financial results for the fourth quarter and full year ended December 31, 2017.

 

CannaRoyalty Corp. (CSE:CRZ) (OTC:CNNRF)

 

Shares of CannaRoyalty Corp. dropped 8.23% today on higher than average trading volume on the OTC markets, closing the day at $3.06 USD per share. Yesterday, CannaRoyalty announced that it has signed a binding term sheet to expand its business relationship with National Access Cannabis Corp. to carry CannaRoyalty products in NAC stores across Canada. The day prior, CannaRoyalty announced that its subsidiary, Trichome Yield Corp. signed its first binding term sheet to provide up to $2.5 million to 180 Smoke, to fund an expansion of its retail footprint.

 

Insys Therapeutics Inc. (NASDAQ:INSY)

 

Shares of Insys Therapeutics Inc. dropped 7.07% today on lower than average trading volume, closing the day at $6.44 USD per share. Recently, Insys announced the initiation of a Phase 3 clinical trial to study cannabidiol oral solution for the treatment of infantile spasms, a rare type of pediatric epilepsy that occurs in very young children, with the first trial site’s activation.

 

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE)

 

Shares of Zynerba Pharmaceuticals, Inc. dropped 7.37% today on higher than average trading volume, closing the day at $9.42 USD per share. Earlier this week, Zynerba announced financial results for the fourth quarter and year ended December 31, 2017 and provided an overview of recent operational highlights.

 

 

Tell us which marijuana stocks burned you today! Join the conversation in our Marijuana Stock Forum!

 

Conclusion

 

Find more about today's losers by checking out their respective profiles in our global marijuana stock database via the linked tickers above. To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on FacebookTwitterStockTwits and Instagram!

 

D/M/O

 

 

Disclaimer

 

Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.

Read more articles tagged:

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.